
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6417445
[patent_doc_number] => 20100167278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/341553
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5048
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167278.pdf
[firstpage_image] =>[orig_patent_app_number] => 12341553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/341553 | Novel Method of Diagnosing, Monitoring, and Staging Prostate Cancer | Dec 21, 2008 | Abandoned |
Array
(
[id] => 6529059
[patent_doc_number] => 20100015166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Therapeutic antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/316621
[patent_app_country] => US
[patent_app_date] => 2008-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7708
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015166.pdf
[firstpage_image] =>[orig_patent_app_number] => 12316621
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/316621 | Therapeutic antibodies | Dec 14, 2008 | Issued |
Array
(
[id] => 5586258
[patent_doc_number] => 20090105460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Antibody and inhibitor, and transfection method or kit using them'
[patent_app_type] => utility
[patent_app_number] => 12/314556
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9111
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105460.pdf
[firstpage_image] =>[orig_patent_app_number] => 12314556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/314556 | Antibody and inhibitor, and transfection method or kit using them | Dec 11, 2008 | Issued |
Array
(
[id] => 5464356
[patent_doc_number] => 20090324556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/314218
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7956
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12314218
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/314218 | Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof | Dec 4, 2008 | Issued |
Array
(
[id] => 5563566
[patent_doc_number] => 20090136418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Peptides specific for hepatocellular carcinoma cells and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 12/292401
[patent_app_country] => US
[patent_app_date] => 2008-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15702
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136418.pdf
[firstpage_image] =>[orig_patent_app_number] => 12292401
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/292401 | Peptides specific for hepatocellular carcinoma cells and applications thereof | Nov 17, 2008 | Issued |
Array
(
[id] => 6070134
[patent_doc_number] => 20110044984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Monoclonal Antibody Capable of Binding to Anexelekto, and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/742947
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22296
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20110044984.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742947
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742947 | Monoclonal antibody capable of binding to anexelekto, and use thereof | Nov 13, 2008 | Issued |
Array
(
[id] => 5452067
[patent_doc_number] => 20090068104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use'
[patent_app_type] => utility
[patent_app_number] => 12/270110
[patent_app_country] => US
[patent_app_date] => 2008-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10156
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068104.pdf
[firstpage_image] =>[orig_patent_app_number] => 12270110
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/270110 | Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use | Nov 12, 2008 | Abandoned |
Array
(
[id] => 5508478
[patent_doc_number] => 20090081685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/268850
[patent_app_country] => US
[patent_app_date] => 2008-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13378
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081685.pdf
[firstpage_image] =>[orig_patent_app_number] => 12268850
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/268850 | METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE | Nov 10, 2008 | Abandoned |
Array
(
[id] => 6280473
[patent_doc_number] => 20100119527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/268302
[patent_app_country] => US
[patent_app_date] => 2008-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21507
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119527.pdf
[firstpage_image] =>[orig_patent_app_number] => 12268302
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/268302 | N-cadherin: target for cancer diagnosis and therapy | Nov 9, 2008 | Issued |
Array
(
[id] => 5385196
[patent_doc_number] => 20090226441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/265154
[patent_app_country] => US
[patent_app_date] => 2008-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 43501
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226441.pdf
[firstpage_image] =>[orig_patent_app_number] => 12265154
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/265154 | ACTIVIN RECEPTOR-LIKE KINASE-1 COMPOSITIONS AND METHODS OF USE | Nov 4, 2008 | Abandoned |
Array
(
[id] => 6502416
[patent_doc_number] => 20100260667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease'
[patent_app_type] => utility
[patent_app_number] => 12/260892
[patent_app_country] => US
[patent_app_date] => 2008-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 50339
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260667.pdf
[firstpage_image] =>[orig_patent_app_number] => 12260892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/260892 | Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease | Oct 28, 2008 | Abandoned |
Array
(
[id] => 5484930
[patent_doc_number] => 20090274695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Inhibition of urokinase-type plasminogen activator (uPA) activity'
[patent_app_type] => utility
[patent_app_number] => 12/290013
[patent_app_country] => US
[patent_app_date] => 2008-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 23862
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274695.pdf
[firstpage_image] =>[orig_patent_app_number] => 12290013
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/290013 | Inhibition of urokinase-type plasminogen activator (uPA) activity | Oct 22, 2008 | Abandoned |
Array
(
[id] => 5284958
[patent_doc_number] => 20090098633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells'
[patent_app_type] => utility
[patent_app_number] => 12/288547
[patent_app_country] => US
[patent_app_date] => 2008-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20905
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12288547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/288547 | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells | Oct 19, 2008 | Issued |
Array
(
[id] => 5564119
[patent_doc_number] => 20090136972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'METHODS FOR THE DIAGNOSIS OF GENITOURINARY CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/253592
[patent_app_country] => US
[patent_app_date] => 2008-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16100
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136972.pdf
[firstpage_image] =>[orig_patent_app_number] => 12253592
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253592 | Methods for the diagnosis of genitourinary cancer | Oct 16, 2008 | Issued |
Array
(
[id] => 6485802
[patent_doc_number] => 20100285474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'DIAGNOSTIC, PREDICTIVE AND PROGNOSTIC TESTING FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/738062
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21463
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285474.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738062 | Diagnostic, predictive and prognostic testing for cancer | Oct 14, 2008 | Issued |
Array
(
[id] => 4464961
[patent_doc_number] => 07935785
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Selective substrates for matrix metalloproteinases'
[patent_app_type] => utility
[patent_app_number] => 12/252160
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24252
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12252160
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/252160 | Selective substrates for matrix metalloproteinases | Oct 14, 2008 | Issued |
Array
(
[id] => 6024267
[patent_doc_number] => 20110052593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'BREAST CANCER ASSOCIATED ANTIGEN'
[patent_app_type] => utility
[patent_app_number] => 12/738211
[patent_app_country] => US
[patent_app_date] => 2008-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 10318
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738211
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738211 | BREAST CANCER ASSOCIATED ANTIGEN | Oct 14, 2008 | Abandoned |
Array
(
[id] => 6622924
[patent_doc_number] => 20100311102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Electrophysiology Methods for Identification of Protein Structures in Membranes Associated to Neurodegenerative Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/682230
[patent_app_country] => US
[patent_app_date] => 2008-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6726
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311102.pdf
[firstpage_image] =>[orig_patent_app_number] => 12682230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/682230 | Real time electrophysiological testing of agents of interest for treatment of amyloid-type diseases | Oct 8, 2008 | Issued |
Array
(
[id] => 7534997
[patent_doc_number] => 08048621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/286291
[patent_app_country] => US
[patent_app_date] => 2008-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 50362
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048621.pdf
[firstpage_image] =>[orig_patent_app_number] => 12286291
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/286291 | Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors | Sep 28, 2008 | Issued |
Array
(
[id] => 5564090
[patent_doc_number] => 20090136943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'METHOD OF DETECTING CANCER USING DELTA-CATENIN'
[patent_app_type] => utility
[patent_app_number] => 12/238539
[patent_app_country] => US
[patent_app_date] => 2008-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10035
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136943.pdf
[firstpage_image] =>[orig_patent_app_number] => 12238539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/238539 | Method of detecting cancer using delta-catenin | Sep 25, 2008 | Issued |